CT angiography works as well as conventional digital subtraction angiography for diagnosing peripheral arterial disease (PAD), researchers reported online in the journal Radiology.
CT angiography works as well as conventional digital subtraction angiography for diagnosing peripheral arterial disease (PAD), researchers reported online in the journal Radiology.
PAD, often a result of atherosclerosis, affects 15 to 20 percent of those over 70, particularly among men, former smokers, and those with diabetes.
An Italian team led by Alessandro Napoli, MD, PhD, of the University of Rome La Sapienza, considered results from 212 patients with symptomatic PAD who underwent 64-section CT angiography and then digital subtraction angiography, or DSA. To analyze arteries with stenosis of 70 percent or greater, the researchers divided the arterial bed into 35 segments, which were then evaluated by three readers.
Evaluating 7,420 segments in all, the team found agreement across the imaging methods in 96 percent of cases and an accuracy of 98 percent for both. They found “no significant difference between CT angiographic and DSA findings,” Napoli and colleagues reported.
Of the patients, 49 patients were referred for conservative treatment, 87 underwent endovascular procedures, 38 underwent surgery, and 17 received hybrid treatment. The therapy recommendations based on CT angiography imaging were identical to those based on DSA findings in all but one patient, the team said, concluding that “The diagnostic performance of 64-section CT angiography is excellent in patients with clinical symptoms of PAD.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.